KAZIA THERAPEUTICS-SPON ADR (KZIA) Stock Earnings & Estimates
USA - NASDAQ:KZIA - US48669G3039 - ADR
7.22 USD
+0.24 (+3.44%)
6.83 USD
-0.39 (-5.4%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.1K -99.99% | 22.6K 976.19% | 2.32M 10,165.49% | 34.17K -98.53% | 51K 49.25% | 31.11K -39.00% | 994.847K 3,097.84% | 32.363M 3,153.06% | 170.66M 427.33% | 353.09M 106.90% | 538.2M 52.43% | |
| EBITDA YoY % growth | N/A -1,735.97% | N/A -9.90% | N/A 124.14% | 7.2M 16.50% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -25.382M -300.46% | -24.125M 4.95% | -27.193M -12.72% | -29.071M -6.90% | -33.188M -14.16% | -35.529M -7.05% | -31.839M 10.39% | -8.547M 73.16% | 117.27M 1,472.04% | 278.2M 137.23% | 436.68M 56.97% | |
| Operating Margin | -1,208,671.43% | -106,745.58% | -1,172.11% | -85,076.12% | -65,075.00% | -114,204.92% | -3,200.41% | -26.41% | 68.72% | 78.79% | 81.14% | |
| EPS YoY % growth | N/A -8,174.48% | N/A 89.43% | N/A 100.20% | -26.52 -236,463.64% | -12.95 51.15% | -10.05 22.44% | -1.45 85.60% | -0.16 88.73% | 8.58 5,362.83% | 17.82 107.72% | 28.07 57.52% |
All data in AUD
| Q4 / 25 | Q2 / 26 | Q4 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -11.27 | -6.89 44.02% | -6.12 45.70% |
| Revenue Q2Q % growth | 8.16K -99.65% | -100.00% | |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -16.607M 10.59% | -19.876M -74.94% | -21.532M -29.66% |
All data in AUD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -12.30 | -17.44 | 5.14 | 29.48% |
| Q4 2023 Q2Q % growth | -9.50 78.19% | -2.55 | -6.95 | -272.55% |
| Q4 2022 Q2Q % growth | -43.55 | -5.10 | -38.45 | -753.92% |
| Q2 2021 Q2Q % growth | -29.50 -23,080.89% | -3.06 | -26.44 | -864.05% |
| Q2 2020 Q2Q % growth | 49.80% | -0.13 | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 28.7K -100.00% | % | ||
| Q2 2024 Q2Q % growth | 6.5K 6,400.00% | % | ||
| Q4 2023 Q2Q % growth | 22.4K -100.00% | 23.46K | -23.46K | -100.00% |
| Q2 2023 Q2Q % growth | 100 -95.00% | % | ||
| Q4 2022 Q2Q % growth | 100 -100.00% | 518.16K | -518.06K | -99.98% |
| Q2 2022 Q2Q % growth | 2K -93.51% | % | ||
| Q4 2021 Q2Q % growth | 15.194M 45,527.93% | % | ||
| Q2 2021 Q2Q % growth | 30.8K -5.52% | 612K | -581.2K | -94.97% |
| Q4 2020 Q2Q % growth | 33.3K -66.57% | % | ||
| Q2 2020 Q2Q % growth | 32.6K 13.19% | 1.522M | -1.49M | -97.86% |
| Q2 2019 Q2Q % growth | 28.8K | 3.12M | -3.091M | -99.08% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | N/A |